• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sorrento Distributes Dividend Confirmation Statements to 146 Brokerage Firms and Provides Specific Instruction to Continental Stock Transfer & Trust Company Regarding the Dividend of Scilex Holding Company Common Stock

    2/3/23 8:59:53 PM ET
    $SCLX
    $SRNE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $SCLX alert in real time by email

    SAN DIEGO, Feb. 03, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today distributed dividend confirmation statements to 146 brokerage firms regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company (NASDAQ:SCLX, "Scilex"))) held by Sorrento. These statements, which contain the account numbers and amount of Scilex dividend shares, were previously mailed out by Continental Stock Transfer & Trust Company.

    The dividend confirmation statements are being distributed on behalf of Sorrento and Scilex to notify each brokerage firm of Sorrento's previously announced stock dividend (the "Dividend") consisting of an aggregate of 76,000,000 shares (the "Dividend Stock") of common stock of Scilex held by Sorrento to record holders of (i) Sorrento's common stock (the "Record Common Holders") as of the close of business on January 9, 2023 (the "Record Date"), and (ii) certain warrants to purchase Sorrento common stock (which have or may have the right to participate in the Dividend pursuant to the terms of their respective warrants).

    According to Sorrento's estimates, approximately 60 million or more shares of Sorrento common stock were sold "short" as of the Record Date. In the event the shares of Sorrento common stock were held through a brokerage firm, bank, dealer or other similar organization and were sold "short" as of the Record Date, holders should consult with their financial advisor, broker or other agent immediately to determine whether they may also be deemed "short" Scilex common stock as a result of the Dividend, as well as any obligations required for you to cover your "short" position(s). Please note that "naked short" sales or "naked short" positions in any Sorrento common stock may constitute a violation of the U.S. Securities and Exchange Commission Regulation SHO.

    Each Record Common Holder is entitled to receive 0.1410127 of a share of Scilex common stock for each one share of Sorrento common stock held by such Record Common Holder as of the close of business on the Record Date. The payment date for the Dividend was January 19, 2023. The resulting fewer number of shares of Scilex common stock that will be available to trade could cause the trading market of the common stock of Scilex to become less liquid. As noted above, Scilex's transfer agent, Continental Stock Transfer & Trust Company ("CST"), has already distributed to brokerage firms, as the Record Common Holder (for the benefit of their customers that held Sorrento common stock on the Record Date), a book-entry/DRS transaction confirmation (the "Dividend Confirmation Statement") reflecting the portion of the Dividend Stock allocated to such firm (for the benefit of their customers that held Sorrento common stock on the Record Date), which Dividend Confirmation Statements were mailed to the addresses on record with The Depository Trust & Clearing Corporation.

    In the event that brokerage firms did not receive copies of the Dividend Confirmation Statements, please contact CST immediately. Sorrento and Scilex are requesting that each brokerage firm distribute the Dividend Stock to the actual beneficial owners thereof and to reflect Scilex's CUSIP number 80880W106 and value of Scilex common stock on each beneficial owner's brokerage statement.  

    Sorrento and Scilex have given specific instructions to Scilex's transfer agent, CST, on how to answer certain inquiries from Record Holders and brokerage firms:

    • When beneficial holders call CST:
      • CST will direct the beneficial holders to contact their brokers.
    • When brokers call CST:
      • CST needs to confirm with the broker that such broker has received their Dividend Confirmation Statement.
      • If brokers did not get the Dividend Confirmation Statement, CST will distribute the Dividend Confirmation Statement again to the applicable broker.

    • CST will communicate to the brokers that Sorrento and Scilex demand that brokers distribute the Scilex common stock to the individual accounts of the beneficial holders.

    • If brokers refuse to distribute the Scilex common stock, Sorrento and Scilex will work with CST and the beneficial holder in exiting their brokerage accounts out of "street" name and into book entry format with CST so that the beneficial holder becomes the direct holder of record with CST. The beneficial holders will be charged $15 for the exit of such positions from their brokerage accounts.

    To obtain a copy of the Dividend Confirmation Statement and to have the Dividend Stock reflected on such Dividend Confirmation Statement further distributed to the actual beneficial owners thereof, please contact Scilex's transfer agent, CST, by phone or email at:

    Continental Stock Transfer & Trust Company

    Telephone Number: 800-509-5586

    Email Address: [email protected]

    Broker List

    Broker NameBroker Address Broker NameBroker Address
    ABN AMRO CLEARING CHICAGO LLC



    https://www.abnamro.com/clearing/en/contact-form







    175 WEST JACKSON BLVD. CHICAGO

    IL ILLINOIS 60604 US
    Albert Fried & Company LLC



    [email protected]



    45 BROADWAY, 24TH FLOOR

    24TH FLOOR NEW YORK NY NEW YORK

    10006 US
    AMALGAMATED BANK



    https://www.amalgamatedbank.com/contact



    275 7TH AVENUE NEW YORK

    NY NEW YORK 10003 US
    AMERICAN ENTERPRISE INVESTMENT SERVICES INC.



    [email protected]
    682 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS

    MN MINNESOTA 55474 US



    Broker NameBroker Address Broker NameBroker Address
    APEX CLEARING CORPORATION



    [email protected]



    2 GATEWAY

    CENTER 283-299 MARKET ST 16TH FLOOR NEWARK

    NJ NEW JERSEY 07102-5005 US
    BANK OF AMERICA, NA/GWIM TRUST OPERATIONS



    1.800.878.7878



    https://www.privatebank.bankofamerica.com/find-an-advisor.html
    901 MAIN STREET

    12TH FLOOR DALLAS

    TX TEXAS 23113 US
    BANK OF NEW YORK MELLON



    [email protected]



    111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE NY NEW YORK 13057 US.
    BARCLAYS CAPITAL INC.



    [email protected]



    DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS- MILLER OR ROBERT MENDEZ

    JERSEY CITY NJ NEW JERSEY

    07310 US
    BARCLAYS CAPITAL INC.



    [email protected]



    DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ JERSEY CITY

    NJ NEW JERSEY 07310 US
    BMO CAPITAL MARKETS CORP.



    https://capitalmarkets.bmo.com/en/contact-us/



    3 2ND STREET

    12TH FLOOR JERSEY CITY NJ NEW JERSEY 07302 US
    BMO HARRIS BANK NA/TRUST



    https://www.bmoharris.com/main/contact-us/

    11270 W PARK PL MILWAUKEE

    WI WISCONSIN 53224 US
    BMO Nesbitt Burns Inc., Toronto



    [email protected]

    250 YONGE STREET,

    7TH FLOOR

    7TH FLOOR TORONTO ON ONTARIO M5B 2M8 CA

    CANADA
    BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME

    BROKERAGE CUSTODIAN

    [email protected]
    100 WEST 33RD STREET

    3RD FLOOR NEW YORK NY NEW YORK

    10001
    BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME

    BROKERAGE CUSTODIAN

    [email protected]
    100 WEST 33RD STREET

    3RD FLOOR NEW YORK NY NEW YORK

    10001
    BNY MELLON



    [email protected]



    PO BOX 392002

    500 ROSS STREET PITTSBURGH

    PA

    PENNSYLVANIA 15262 US
    BNY MELLON/WEALTH MANAGEMENT



    [email protected]



    1 FREEDOM VALLEY DRIVE

    OAKS

    PA PENNSYLVANIA 19456 US
    BNYMELLON



    [email protected]
    111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE
    BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD.



    [email protected]
    ONE WALL STREET NEW YORK

    NY NEW YORK 10286



    Broker NameBroker Address Broker NameBroker Address
     NY NEW YORK 13057 US  
    BNYMELLON/RE CACEIS BANK LUXEMBOURG



    [email protected]



    500 Grant St.

    BNY Mellon Center PITTSBURGH

    PA PENNSYLVANIA

    15258
    BNYMELLON/RE CACEIS BANK, NETHERLANDS



    [email protected]



    111 SANDERS CREEK PARKWAY

    EAST SYRACUSE NY NEW YORK 13057
    BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED



    [email protected]



    111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE NY NEW YORK

    13057 US
    BNYMELLON/RE ETF - ISHARES DTC/NSCC



    [email protected]

    111 SANDERS CREEK PARKWAY

    EAST SYRACUSE NY NEW YORK 13057
    BNYMELLON/RE WINTERFLOOD SECURITIES LTD



    [email protected]

    500 Grant St.

    BNY Mellon Center PITTSBURGH

    PA PENNSYLVANIA 15258
    BOFA



    [email protected]

    4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BOFA



    [email protected]



    4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BOFA

    SECURITIES INC



    [email protected]



    4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BROWN BROTHERS HARRIMAN & CO.



    [email protected]



    140 BROADWAY ATTN: CORPORATE ACTIONS VAULT NEW YORK

    NY NEW YORK 10005 US
    BROWN BROTHERS HARRIMAN & CO./ETF



    [email protected]



    140 BROADWAY NEW YORK

    NY NEW YORK 10005
    CALDWELL SECURITIES LTD./CDS**



    [email protected]



    55 UNIVERSITY AVENUE

    SUITE 340 TORONTO ON ONTARIO

    M5J 2H7 CANADA
    CANACCORD GENUITY CORP.



    [email protected]



    609 GRANVILLE ST VANCOUVER

    BC BRITISH COLUMBIA

    V7Y 1H2 CA CANADA
    CANTOR, FITZGERALD & CO.



    https://www.cantor.com/investor-center/



    135 E 57TH ST 5TH FL

    NEW YORK

    NY NEW YORK 10041 US
    CDS CLEARING AND DEPOSITORY SERVICES INC.



    [email protected]
    100 ADELAIDE STREET WEST TORONTO

    ON ONTARIO

    M5H 1S3 CA CANADA
    CETERA INVESTMENT SERVICES LLC



    [email protected]
    400 FIRST STREET

    SOUTH, SUITE 300

    SUITE 300 ST. CLOUD
    CHARLES SCHWAB & CO., INC.



    800-435-4000



    https://www.schwab.com/contact-us

    211 MAIN STREET SAN FRANCISCO CA CALIFORNIA

    94105 US



    Broker NameBroker Address Broker NameBroker Address
     MN MINNESOTA 56302-0283 US  
    CI INVESTMENT SERVICES INC.



    [email protected]
    199 BAY STREET

    SUITE 2600 TORONTO ON ONTARIO M5L 1E2 CA

    CANADA
    CIBC WORLD MARKETS INC./CDS**



    [email protected].



    161 BAY STREET 10 FL

    TORONTO ON ONTARIO

    M5J 2S8 CA CANADA
    CITIBANK, N.A./ETF





    1-800-950-5114
    3800 CITIGROUP CENTER

    B2/2 TAMPA

    FL FLORIDA 33610
    CITIBANK, NATIONAL ASSOCIATION





    1-800-950-5114

    3800 CITIBANK CENTER TAMPA BLDG.B FIRST FLOOR ZONE 8 TAMPA

    FL FLORIDA 33610-9122 US
    CITIGROUP GLOBAL MARKETS, INC.



    1-800-950-5114



    580 CROSSPOINT PARKWAY GETZVILLE

    NY NEW YORK 14068 US
    CLEAR STREET LLC







    https://clearstreet.io/contact



    4 World Trade Center, 45th Floor

    150 Greenwich Street NEW YORK

    NY NEW YORK 10007
    CLEARSTREET IO





    [email protected]







    55 BROADWAY

    (SUITE 2102) CORPORATE ACTIONS NEW YORK

    NEW YORK 10006 US
    COMMERCE BANK







    [email protected]



    922 WALNUT STREET MAIL STOP TBTS-2 KANSAS CITY

    MO MISSOURI 64106 US
    COR CLEARING LLC



    [email protected]





    9300 UNDERWOOD AVE

    SUITE 400 OMAHA

    NE NEBRASKA 68114 US
    Credential Securities Inc.







    [email protected]



    800-1111 WEST GEORGIA STREET VANCOUVER

    BC BRITISH COLUMBIA

    V6E 4T6 CA CANADA
    CREST INTERNATIONAL NOMINEES LIMITED







    [email protected]





    33 CANNON STREET LONDON EC4M 5SB GB

    UNITED KINGDOM
    CURVATURE SECURITIES, LLC







    [email protected]

    39 MAIN STREET CHATHAM

    NJ NEW JERSEY 07928 US
    D.A. DAVIDSON & CO.







    https://dadavidson.com/Contact-Us





    8 3RD STREET NORTH GREAT FALLS MT MONTANA

    59401 US
    DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE

    VALORES



    https://www.dcv.cl/en/contact.html





    AVENIDA APOQUINDO # 4001

    FLOOR 12, C.P.

    7550162, SANTIAGO CL CHILE



    Broker NameBroker Address Broker NameBroker Address
    DESJARDINS SECURITIES INC.



    [email protected]





    1253 McGill College 10TH FLOOR MONTREAL QUEBEC

    H3B 2Y5 CA CANADA
    DEUTSCHE BANK AG NY/US CUSTODY



    [email protected]
    1251 Avenue Of The Americas

    NEW YORK NY NEW YORK 10020
    DEUTSCHE BANK SECURITIES INC.



    [email protected]



    60 WALL STREET

    9TH FLOOR NEW YORK NY NEW YORK 10005 US
    DRIVEWEALTH, LLC



    https://www.drivewealth.com/lets-build-together/



    15 EXCHANGE PLACE

    10TH FLOOR JERSEY CITY

    NEW JERSEY 07302
    E*TRADE CLEARING LLC



    https://us.etrade.com/contact-us



    HARBORSIDE FINANCIAL CENTER

    501 PLAZA 11 JERSEY CITY

    NJ NEW JERSEY 07311 US
    EDWARD D. JONES & CO., L.P.



    1 (800) 441-2357



    12555 MANCHESTER ROAD

    ST. LOUIS

    MO MISSOURI 63131-3729 US
    EDWARD D. JONES & CO., L.P.



    1 (800) 441-2357
    201 PROGRESS PARKWAY MARYLAND HEIGHTS

    MO MISSOURI 63043 US
    FIDELITY CLEARING CANADA

    ULC/CDS**



    [email protected]





    483 BAY ST. SOUTH TOWER TORONTO

    ON ONTARIO M5G2N7 CA CANADA
    FIFTH THIRD BANK



    1-866-671-5353

    5001 KINGSLEY DRIVE

    MAIL DROP 1MOB28 CINCINNATI

    OH OHIO 45227 US
    FOLIO INVESTMENTS, INC.



    https://folioinvesting.com/folioinvesting/contact-us/



    8180 GREENSBORO DRIVE

    8TH FLOOR MCLEAN

    VA VIRGINIA 22102 US
    FUTU CLEARING INC.



    [email protected]







    12750 Merit Drive

    SUITE 475 DALLAS TX TEXAS 75251
    GMP SECURITIES L.P.



    416 943 6696
    145 KING STREET

    WEST, SUITE 300 11TH FLOOR TORONTO

    ON ONTARIO

    MJ5 1J8 CA CANADA
    GOLDMAN, SACHS & CO. LLC





    [email protected].



    222 SOUTH MAIN STREET

    Attn: Mandatory Corporate Actions SALT LAKE CITY UT UTAH

    84101 US
    HAYWOOD SECURITIES INC./CDS**



    https://www.haywood.com/who-we-are/locations



    200 BURRARD ST WATERFRONT CENTRE SUITE 700 VANCOUVER

    BC BRITISH COLUMBIA

    V6C 3L6 CANADA
    HILLTOP SECURITIES INC.



    https://www.hilltopsecurities.com/contact/

    1201 ELM ST.

    35TH FLOOR DALLAS

    TX TEXAS

    75270 US
    HRT FINANCIAL LLC



    [email protected]







    150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE

    CENTER



    Broker NameBroker Address Broker NameBroker Address
       57TH FLOOR NEW YORK NY NEW YORK

    10007 US
    HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR

    STOCK LOAN



    https://www.us.hsbc.com/customer-service/contact-us/





    452 FIFTH AVENUE ATTN: HBUS CCS SETTS

    NEW YORK NY NEW YORK

    10018 US
    HSBC BANK USA, NATIONAL ASSOCIATION



    [email protected]



    452 FIFTH AVENUE ATTN: HBUS CCS SETTS

    NEW YORK NEW YORK

    10018 US
    INTERACTIVE BROKERS LLC



    877-442-2757
    2 PICKWICK PLAZA

    2ND FLOOR GREENWICH

    CT CONNECTICUT

    06830 US
    J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF



    https://am.jpmorgan.com/us/en/asset-management/adv/contact-us/





    1111 POLARIS PARKWAY COLUMBUS OH OHIO

    43240
    J.P. MORGAN CLEARING CORP.



    (347) 643-1000
    FOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    JANNEY MONTGOMERY SCOTT LLC



    [email protected]



    1717 ARCH STREET

    17TH FLOOR PHILADELPHIA

    PA PENNSYLVANIA 19103 US
    JEFFERIES LLC





    https://www.jefferies.com/FooterPages/Contact-Us/94



    101 HUDSON

    STREET, 11th Floor NEW JERSEY

    NJ NEW JERSEY 07302 US
    JPMORGAN CHASE BANK, NATIONAL ASSOCIATION



    [email protected]



    FOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    JPMORGAN CHASE BANK/EUROCLEAR BANK



    [email protected]
    FOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11245 US
    JPMORGAN CHASE BANK/IA



    [email protected]
    FOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    KEYBANK NATIONAL ASSOCIATION



    https://www.key.com/personal/customer-support/contact-us.html



    4900 TIEDEMAN RD BROOKLYN

    OH OHIO 44144 US
    LAURENTIAN BANK SECURITIES INC.



    https://www.vmbl.ca/portal/web/site_public/contactez-nous



    1981 MCGILL COLLEGE AVE. SUITE 100 MONTREAL QUEBEC

    H3A 3K3 CA CANADA
    LPL FINANCIAL LLC



    [email protected]



    4707 EXECUTIVE DRIVE

    SAN DIEGO

    CA CALIFORNIA 92121 US
    MANUFACTURERS AND TRADERS TRUST COMPANY



    https://www3.mtb.com/homepage/explore-the-m-and-t-bank-help-center/mandt-bank-phone-numbers-by-department/telephone-directory



    ONE M&T PLAZA TRUST OPS 8TH FLOOR BUFFALO

    NY NEW YORK 14203 US



    Broker NameBroker Address Broker NameBroker Address
    MANULIFE SECURITIES INCORPORATED



    [email protected]



    1235 NORTH SERVICE ROAD WEST OAKVILLE

    ON ONTARIO

    L6M 2W2 CA CANADA
    MARSCO INVESTMENT CORPORATION



    [email protected]



    101 EISENHOWER PARKWAY ROSELAND

    NJ NEW JERSEY 07068 US
    MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED



    https://www.ml.com/contactus/contact-us.html







    4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT



    212-407-1000
    810 SEVENTH AVE

    37TH FLOOR NEW YORK

    NY NEW YORK 10019
    MIRAE ASSET SECURITIES (USA), INC.



    212-407-1000



    810 SEVENTH AVE

    37TH FLOOR NEW YORK NY NEW YORK 10019
    MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK

    BRANCH

    https://safe.tr.mufg.jp/cgi-bin/english/index_contact/index_contact_01.cgi?r=7
    280 PARK AVE

    39TH FL-WEST BLDG NEW YORK

    NY NEW YORK 10017
    Morgan Stanley



    [email protected]



    1300 THAMES STREET

    THAMES STREET WHARF BALTIMORE

    MD MARYLAND 21231 US
    MORGAN STANLEY & CO. LLC



    [email protected]



    1300 THAMES ST. BALTIMORE

    MD MARYLAND
    MORGAN STANLEY SMITH BARNEY LLC



    [email protected]
    1 NEW YORK PLAZA

    39TH FLOOR NEW YORK

    NY NEW YORK 10004 US
    MURIEL SIEBERT & CO., INC.



    [email protected]



    77 SUMMER STREET

    3RD FLOOR BOSTON MA

    MASSACHUSETTS 02210 US
    NATIONAL FINANCIAL SERVICES LLC



    http://www.national-financial-services.com/contact_us/





    499 WASHINGTON BOULEVARD

    5TH FLOOR JERSEY CITY NJ NEW JERSEY

    07310 US
    NBCN INC.



    [email protected]







    1010 rue De La Gauchetière Mezzanine 100 MONTREAL QUEBEC

    H3B 5J2 CA CANADA
    NOMURA INTERNATIONAL TRUST COMPANY



    https://www.nomuraholdings.com/news/contact/



    309 WEST 49TH STREET

    10TH FLOOR NEW YORK NY NEW YORK

    10019 US
    ODLUM BROWN LIMITED



    [email protected]



    250 HOWE STREET

    SUITE 1100 VANCOUVER BC BRITISH COLUMBIA

    V6C 3R8 CA CANADA
    OPPENHEIMER & CO. INC.



    [email protected]







    85 BROAD STREET NEW YORK

    NY NEW YORK 10004 US
    PERSHING LLC



    https://www.pershing.com/contact/



    1 PERSHING PLAZA JERSEY CITY

    NJ NEW JERSEY 07399 US



    Broker NameBroker Address Broker NameBroker Address
    PHILLIP CAPITAL INC.



    [email protected]







    141 W. JACKSON

    BLVD. SUITE 3050 CHICAGO

    IL ILLINOIS 60604 US
    PI FINANCIAL CORP.



    [email protected]



    666 BURRARD ST

    SUITE 1900 VANCOUVER BC BRITISH COLUMBIA

    V6C 3N1 CA CANADA
    PNC BANK, NATIONAL ASSOCIATION



    [email protected] 



    4100 W 150TH STREET

    ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7- YB17-03-03 CLEVELAND

    OH OHIO 44135 US
    PRINCIPAL BANK



    https://www.principal.com/contact-us



    711 HIGH STREET DES MOINES

    IA IOWA 50392
    QUESTRADE INC./CDS**



    [email protected]



    5650 YONGE ST.,

    Suite 1700 TORONTO ON ONTARIO M2M 4G3 CA

    CANADA
    Raymond James & Associates, Inc.



    [email protected]



    880 CARILLON PKWY ST. PETERSBURG

    FL FLORIDA 33733-2749 US
    RAYMOND JAMES LTD.



    [email protected]



    925 WEST GEORGIA STREET SUITE 2200 VANCOUVER



    BC BRITISH COLUMBIA V6C 3L2 CA

    CANADA
    RBC CAPITAL MARKETS, LLC



     [email protected]



    60 SOUTH 6TH ST. MINNEAPOLIS MN MINNESOTA 55402 US
    RBC DOMINION SECURITIES INC



    [email protected]



    21 COMMERCE COURT SOUTH 2ND FLOOR TORONTO

    ON ONTARIO

    M5L 1A7 CANADA
    RELIANCE TRUST COMPANY



    https://www.reliancetrustgroup.com/contact



    1100 ABERNATHY RD.

    500 NORTHPARK

    SUITE 400 ATLANTA GA GEORGIA

    30113 US
    RELIANCE TRUST COMPANY



    [email protected]



    4900 W. BROWN DEER RD MILWAUKEE WI WISCONSIN 53223 USROBERT W. BAIRD & CO. INCORPORATED



    [email protected]



    777 E WISCONSIN AVE

    9TH FLOOR MILWAUKEE WI WISCONSIN

    53202 US
    ROBINHOOD SECURITIES, LLC



    [email protected]



    500 COLONIAL CENTER PARKWAY SUITE 100 LAKE MARY FL FLORIDA

    32746 US
    SAFRA SECURITIES LLC



    https://www.safrasecurities.com/Contact.aspx



    546 5TH AVENUE NEW YORK

    NY NEW YORK 10036 US



    Broker NameBroker Address Broker NameBroker Address
    SCOTIA CAPITAL (USA) INC.



    [email protected]



    150 KING STREET W

    5TH FLOOR TORONTO ON ONTARIO M5H 1J9 CA

    CANADA
    SEI PRIVATE TRUST COMPANY



    https://www.seic.com/contact-us



    1 FREEDOM VALLEY DRIVE

    OAKS

    PA PENNSYLVANIA 19456 US
    SEI PRIVATE TRUST COMPANY



    https://www.seic.com/contact-us



    1 FREEDOM VALLEY DRIVE OAKS

    PA PENNSYLVANIA

    19456 US
    SG AMERICAS SECURITIES, LLC



    https://americas.societegenerale.com/en/contact/



    480 WASHINGTON BLVD.

    20TH FLOOR JERSEY CITY NJ NEW JERSEY

    07310 US
    SSB - BLACKROCK INSTITUTIONAL TRUST



    [email protected]



    50 California Street San Francisco

    CA CALIFORNIA 94163
    SSB - TRUST CUSTODY



     [email protected]



    30 ADELAIDE ST EAST

    SUITE 800 TORONTO ON ONTARIO M5C 3G6 CA

    CANADA
    SSB&T CO/CLIENT CUSTODY SERVICES



    https://www.ssbtexas.com/contact



    1776 HERITAGE DRIVE

    NORTH QUINCY MA

    MASSACHUSETTS 02171
    STATE STREET BANK & TRUST CO



    [email protected]
    16 WALL STREET

    5TH FLOOR NEW YORK

    NY NEW YORK 10005 US
    STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE



    [email protected]



    1776 HERITAGE DRIVE

    NORTH QUINCY MA MASSACHUSETTS

    02171
    STATE STREET BANK & TRUST/STATE STREET TOTALETF



    [email protected]



    1776 Heritage Drive NORTH QUINCY MA MASSACHUSETTS 02717
    STATE STREET BANK AND TRUST COMPANY



    [email protected]



    30 ADELAIDE ST EAST

    SUITE 800 TORONTO ON ONTARIO

    M5C 3G6 CA CANADA
    STIFEL, NICOLAUS & COMPANY, INCORPORATED

    [email protected]



    501 N BROADWAY ST. LOUIS

    MO MISSOURI 63102 US
    STONEX FINANCIAL INC.

    [email protected]



    2 PERIMETER PARK SOUTH SUITE 100 W BIRMINGHAM AL ALABAMA

    35243 US
    TD AMERITRADE CLEARING, INC.



    https://www.tdameritrade.com/why-td-ameritrade/contact-us.html







    200 S 108TH AVE OMAHA

    NE NEBRASKA 68154 US
    TD WATERHOUSE CANADA INC ATTN: MANDATORY



    https://www.tdameritrade.com/why-td-ameritrade/contact-us.html
    77 BLOOR STREET WEST

    3RD FLOOR TORONTO

    ON ONTARIO

    M5S 1M2 CA CANADA



    TEXAS TREASURY SAFEKEEPING TRUST COMPANY



    [email protected]
    208 E 10TH ST AUSTIN

    TX TEXAS 78701 US



    Broker NameBroker Address Broker NameBroker Address
        
    THE BANK OF NEW YORK MELLON



    [email protected]



    500 GRANT STREET

    27TH FLOOR PITTSBURGH PA

    PENNSYLVANIA 15258 US
    THE HUNTINGTON NATIONAL BANK



    https://www.huntington.com/customer-service/contact-us



    7 EASTON OVAL EA4E62 COLUMBUS

    OH OHIO 43209 US
    THE NORTHERN TRUST COMPANY



    https://www.northerntrust.com/united-states/contact-us-corporate-overview
    333 South Wabash Ave, 32nd Floor Attn: Trade Securities Processing CHICAGO

    IL ILLINOIS 60603 US
    TRADESTATION SECURITIES, INC



    [email protected]
    120 RIVERSIDE PLAZA

    SUITE 1650 CHICAGO IL ILLINOIS 60606 US
    U.S. BANCORP INVESTMENTS, INC.

    [email protected]



    60 LIVINGSTON AVE

    EP-MN-WN1B ST. PAUL

    MN MINNESOTA 55107-1419 US
    U.S. BANK N.A./ETF



    https://www.usbank.com/investment-services/contact-us.html



    1555 N RIVER CENTER DRIVE MILWAUKEE WI WISCONSIN 53212
    U.S. BANK NATIONAL ASSOCIATION



    https://www.usbank.com/investment-services/contact-us.html
    1555 NORTH RIVERCENTER DRIVE, SUITE 302

    SUITE 302 MILWAUKEE

    WI WISCONSIN 53212 US
    UBS AG



    https://www.ubs.com/global/en/our-firm/locations.html



    480 WASHINGTON BLVD.

    12TH FLOOR JERSEY CITY NJ NEW JERSEY 07310 US
    UBS FINANCIAL SERVICES INC.

    [email protected]











    1000 HARBOR BOULEVARD WEEHAWKEN NJ NEW JERSEY

    07086 US
    UBS SECURITIES LLC



    https://www.ubs.com/us/en/wealth-management/contact-us.html



    677 WASHINGTON BLVD

    STAMFORD

    CT CONNECTICUT 06901 US



    Broker NameBroker Address Broker NameBroker Address
    UMB BANK, NATIONAL ASSOCIATION

    [email protected]



    928 GRAND BLVD KANSAS CITY MO MISSOURI 64106 USVANGUARD MARKETING CORPORATION



    https://corporate.vanguard.com/content/corporatesite/us/en/corp/contact-us.html
    100 VANGUARD BLVD MALVERN

    PA PENNSYLVANIA 19355 US
    VELOCITY CLEARING, LLC

    [email protected]



    1301 Route 36

    Suite 109 (Attn: Chris Felicetti)

    HAZLET

    NEW JERSEY 7730 US
    VELOX CLEARING LLC

    [email protected]



    2400 E. KATELLA AVENUE

    SUITE 725A ANAHEIM

    CA CALIFORNIA 92806 US
    VIRTU AMERICAS LLC



    [email protected]



    ONE LIBERTY PLAZA, 165 BROADWAY 5TH FLOOR NEW YORK NY NEW YORK

    10006 US
    VISION FINANCIAL MARKETS LLC

    [email protected]



    4 HIGH RIDGE PARK SUITE 100 STAMFORD

    CT CONNECTICUT 06905 US
    WEDBUSH SECURITIES INC

    [email protected]



    1000 WILSHIRE BLVD

    8TH FLOOR LOS ANGELES

    CA CALIFORNIA

    90017 US
    WEDBUSH SECURITIES INC.

    [email protected]



    1000 WILSHIRE BLVD.

    LOS ANGELES CA CALIFORNIA 90017 US
    WELLS FARGO BANK, N.A./SIG



    https://www.wellsfargo.com/help/contact-us/



    733 MARQUETTE AVE 4TH FLOOR MAC N9306-04D MINNEAPOLIS

    MN MINNESOTA 55402 US
    WELLS FARGO CLEARING SERVICES LLC



    https://www.wellsfargo.com/help/contact-us/



    1 NORTH JEFFERSON MAIL CODE: H0006- 094

    ST. LOUIS

    MO MISSOURI 63103 US
    WELLS FARGO SECURITIES, LLC



    https://www.wellsfargo.com/help/contact-us/



    1525 WEST W T HARRIS BLVD CHARLOTTE NC NORTH CAROLINA

    28262 US
    WILSON-DAVIS & CO., INC.

    [email protected]



    236 SOUTH MAIN STREET

    SALT LAKE CITY UT UTAH

    84101 US

    About Sorrento Therapeutics, Inc.

    Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors ("TKIs"), fully human antibodies ("G-MAB™ library"), immuno-cellular therapies ("DAR-T™"), antibody-drug conjugates ("ADCs"), and oncolytic virus ("Seprehvec™"). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™.

    Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin ("RTX"), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018.

    For more information visit www.sorrentotherapeutics.com

    Media and Investor Relations

    Contact: Brian Cooley

    Email: [email protected]

    Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

    G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of Sorrento Therapeutics, Inc.

    SEMDEXA™ (SP-102) is a trademark of Semnur Pharmaceuticals, Inc. A proprietary name review by the FDA is planned.

    ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc. All other trademarks are the property of their respective owners.

    ©2023 Sorrento Therapeutics, Inc. All Rights Reserved.



    Primary Logo

    Get the next $SCLX alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SCLX
    $SRNE

    CompanyDatePrice TargetRatingAnalyst
    Scilex Holding Company
    $SCLX
    1/27/2025$22.00Buy
    D. Boral Capital
    Scilex Holding Company
    $SCLX
    10/16/2024$14.00Buy
    Alliance Global Partners
    Scilex Holding Company
    $SCLX
    6/13/2024$13.00Buy
    Rodman & Renshaw
    Scilex Holding Company
    $SCLX
    10/16/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/13/2023$4.00Buy
    B. Riley Securities
    Scilex Holding Company
    $SCLX
    10/9/2023$12.00Buy
    H.C. Wainwright
    Sorrento Therapeutics Inc.
    $SRNE
    11/2/2022$5.00Overweight
    Cantor Fitzgerald
    Sorrento Therapeutics Inc.
    $SRNE
    8/9/2021$30.00 → $26.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SCLX
    $SRNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Scilex Holding Company to Present Post-Hoc Analysis of the C.L.E.A.R. Trial on Clinical Meaningfulness of Safety and Efficacy of SP-102 for the Treatment of Lumbosacral Radicular Pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP), May 15-17, 2025 in Orlando, FL.

      PALO ALTO, Calif., May 01, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced an upcoming presentation of post-hoc analysis of the C.L.E.A.R. trial (Corticosteroid Lumbar Epidural Analgesia in Radiculopathy) interpreting clinical meaningfulness of safety and efficacy of SP-102 (SEMDEXA™) for the treatment of lumbosacral radicular pain (LRP) at the 27th Annual Meeting of American Society of Interventional Pain Physicia

      5/1/25 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule

      PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that it has received notification from The Nasdaq Stock Market LLC that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2). To regain compliance, the Company was required to maintain a minimum closing bid price of $1.00 per share for at least ten consecutive trading days.

      4/30/25 1:46:47 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

      PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors has approved changing the previously announced record date of April 11, 2025 for its previously announced dividend of Scilex preferred stock (the "Dividend") to its stockholders and certain other securityholders of Scilex. The new record date for the Dividend will be May 2, 2025 (the "New Record Date"). Subject

      4/22/25 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $SCLX
    $SRNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • D. Boral Capital initiated coverage on Scilex Holding with a new price target

      D. Boral Capital initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $22.00

      1/27/25 8:08:33 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Alliance Global Partners initiated coverage on Scilex Holding with a new price target

      Alliance Global Partners initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $14.00

      10/16/24 8:01:57 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Rodman & Renshaw initiated coverage on Scilex Holding with a new price target

      Rodman & Renshaw initiated coverage of Scilex Holding with a rating of Buy and set a new price target of $13.00

      6/13/24 7:16:15 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $SCLX
    $SRNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Officer Shah Jaisim bought $13,800 worth of shares (30,000 units at $0.46), increasing direct ownership by 27% to 139,333 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      12/18/24 7:04:41 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Executive Chairperson Ji Henry bought $8,351 worth of shares (8,888 units at $0.94), increasing direct ownership by 3% to 320,161 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      10/31/24 12:44:57 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Officer Shah Jaisim bought $31,670 worth of shares (32,000 units at $0.99), increasing direct ownership by 41% to 109,333 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      10/29/24 6:59:31 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $SCLX
    $SRNE
    Leadership Updates

    Live Leadership Updates

    See more
    • Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.

      PALO ALTO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or the "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced that it has added to its Board of Directors a highly accomplished leader in interventional and multidisciplinary spine, musculoskeletal and orthopedic care, Annu Navani, M.D. Dr. Navani has served as the Chief Executive Officer of Comprehensive Spine and Sports Center since 2008, a leader in interventional and multidisciplinary spine, musculoskeletal, and orthopedic care. Over th

      7/23/24 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates

      PALO ALTO, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain, today announced the launch of its redesigned website showcasing the Company's growing portfolio of non-opioid pain management therapeutics. The new website can be accessed by visiting www.scilexholding.com, The features of the new and improved website include: Sleek, modern web design with dynamic elements and illustrations;An overview of the Company's science and expanded product portfolio and pr

      3/4/24 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors

      PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex"), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services ("HHS") and former Governor of Wisconsin, to its Board of Directors. Governor Thompson's appointment is effective immediately. Governor Thompson currently serves as the Chief Executive Officer of Thomp

      7/5/22 2:04:42 PM ET
      $SRNE
      $VCKA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Biotechnology: Biological Products (No Diagnostic Substances)

    $SCLX
    $SRNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Sclx Stock Acquisition Jv Llc disposed of 3,250,000 shares, decreasing direct ownership by 6% to 51,039,214 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      1/23/25 7:49:49 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Large owner Sclx Stock Acquisition Jv Llc disposed of 779,371 shares, decreasing direct ownership by 1% to 54,289,214 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      1/17/25 8:27:54 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Large owner Sclx Stock Acquisition Jv Llc disposed of 5,000,000 shares, decreasing direct ownership by 8% to 55,068,585 units (SEC Form 4)

      4 - Scilex Holding Co (0001820190) (Issuer)

      1/6/25 7:12:44 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care

    $SCLX
    $SRNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

      SC 13D/A - Scilex Holding Co (0001820190) (Subject)

      4/25/24 5:25:28 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form SC 13D/A filed by Scilex Holding Company (Amendment)

      SC 13D/A - Scilex Holding Co (0001820190) (Subject)

      3/5/24 4:22:28 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form SC 13G/A filed by Sorrento Therapeutics Inc. (Amendment)

      SC 13G/A - Sorrento Therapeutics, Inc. (0000850261) (Subject)

      3/10/23 11:21:36 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SCLX
    $SRNE
    Financials

    Live finance-specific insights

    See more
    • Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025

      PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced that its Board of Directors has approved changing the previously announced record date of April 11, 2025 for its previously announced dividend of Scilex preferred stock (the "Dividend") to its stockholders and certain other securityholders of Scilex. The new record date for the Dividend will be May 2, 2025 (the "New Record Date"). Subject

      4/22/25 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

      PALO ALTO, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and, following the formation of its proposed joint venture with IPMC Company, neurodegenerative and cardiometabolic disease, today announced that its Board of Directors has approved changing the previously announced record date of January 28, 2025 for its previously announced dividend of Scilex preferred stock (the "Dividend") to its stockholders and certain other securityholders of Scilex. The new record

      3/10/25 9:00:00 AM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

      US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.Scilex's transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to April 14, 2025. PALO ALTO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain manag

      1/31/25 9:00:00 AM ET
      $SCLX
      $SRNE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch

    $SCLX
    $SRNE
    SEC Filings

    See more
    • Amendment: SEC Form SCHEDULE 13G/A filed by Scilex Holding Company

      SCHEDULE 13G/A - Scilex Holding Co (0001820190) (Subject)

      5/8/25 4:15:17 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form POS AM filed by Scilex Holding Company

      POS AM - Scilex Holding Co (0001820190) (Filer)

      5/7/25 5:30:11 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
    • SEC Form POS AM filed by Scilex Holding Company

      POS AM - Scilex Holding Co (0001820190) (Filer)

      5/7/25 5:24:45 PM ET
      $SCLX
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care